Cargando…

Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 Pneumonia

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)-infection is associated with an extremely variable disease course. When interstitial pneumonia (IP) occurs, it can lead to acute respiratory distress syndrome and death. Serum Krebs von den Lungen-6 (KL-6) is an established marker of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kattner, Simone, Sutharsan, Sivagurunathan, Berger, Marc Moritz, Limmer, Andreas, Jehn, Lutz-Bernhard, Herbstreit, Frank, Brenner, Thorsten, Taube, Christian, Bonella, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648641/ https://www.ncbi.nlm.nih.gov/pubmed/37959236 http://dx.doi.org/10.3390/jcm12216772

Ejemplares similares

Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease
por: Jehn, Lutz B., et al.
Publicado: (2023)

Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis
por: Bonella, Francesco, et al.
Publicado: (2013)

Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T – a case report
por: Welsner, Matthias, et al.
Publicado: (2019)

MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis
por: Bonella, Francesco, et al.
Publicado: (2016)

Changes in Clinical Markers During A Short-Term Transfer Program of Adult Cystic Fibrosis Patients from Pediatric to Adult Care
por: Welsner, Matthias, et al.
Publicado: (2019)

The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19
por: Schönfelder, Kristina, et al.
Publicado: (2021)

Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study
por: Schönfelder, Kristina, et al.
Publicado: (2021)

How personality influences health outcomes and quality of life in adult patients with cystic fibrosis
por: Niehammer, Ute, et al.
Publicado: (2023)

Recombination Drives Evolution of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 KL47 to KL64 in China
por: Chen, Tao, et al.
Publicado: (2023)

Characteristics of Critically Ill Patients with COVID-19 Compared to Patients with Influenza—A Single Center Experience
por: Herbstreit, Frank, et al.
Publicado: (2021)

Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlation
por: Niehammer, Ute, et al.
Publicado: (2022)

Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease State
por: Limmer, Andreas, et al.
Publicado: (2023)

Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
por: Scotto, Riccardo, et al.
Publicado: (2021)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Keynote Lectures (KL)
Publicado: (2017)

Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features
por: Wang, Jingxian, et al.
Publicado: (2020)

Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia
por: Kim, Si-Ho, et al.
Publicado: (2022)

Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients
por: Kattner, Simone, et al.
Publicado: (2023)

Impact of Ninjin’yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice
por: Amitani, Haruka, et al.
Publicado: (2022)

Trainability of Health-Related and Motor Performance Fitness in Adults with Cystic Fibrosis within a 12-Month Partially Supervised Exercise Program
por: Welsner, Matthias, et al.
Publicado: (2021)

Gallbladder cancer detected by elevated serum KL-6 levels during the follow-up of interstitial pneumonia: a case report
por: Yonenaga, Yoshikuni, et al.
Publicado: (2021)

Draft Genome Sequences of Pseudomonas moraviensis UCD-KL30, Vibrio ostreicida UCD-KL16, Colwellia sp. Strain UCD-KL20, Shewanella sp. Strain UCD-KL12, and Shewanella sp. Strain UCD-KL21, Isolated from Seagrass
por: Lujan, Karley M., et al.
Publicado: (2017)

Review of Kl3 theory
por: Callan, C
Publicado: (1969)

Regulatory T cell enhancement in adults with cystic fibrosis receiving Elexacaftor/Tezacaftor/Ivacaftor therapy
por: Westhölter, Dirk, et al.
Publicado: (2023)

The Origins of ST11 KL64 Klebsiella pneumoniae: a Genome-Based Study
por: Wang, Junna, et al.
Publicado: (2023)

Seasonal variation of serum KL-6 concentrations is greater in patients with hypersensitivity pneumonitis
por: Ohnishi, Hiroshi, et al.
Publicado: (2014)

Measurement of the KL0 → $\pi \mu \nu$ absolute decay rate; further results on KL0 → $\pi$ e $\nu$ , and measurement of the KL0 mean life
por: Lowys, J P, et al.
Publicado: (1967)

KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome
por: Kida, Yoshiko, et al.
Publicado: (2012)

Investigation of respiratory rate in patients with cystic fibrosis using a minimal-impact biomotion system
por: Straßburg, Svenja, et al.
Publicado: (2022)

Effects of a Long-Term Monitored Exercise Program on Aerobic Fitness in a Small Group of Children with Cystic Fibrosis
por: Gruber, Wolfgang, et al.
Publicado: (2022)

Elevated serum 1,25(OH)(2)-vitamin D(3) level attenuates renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction in kl/kl mice
por: Sun, Yujing, et al.
Publicado: (2014)

Biomarkers extracted by fully automated body composition analysis from chest CT correlate with SARS-CoV-2 outcome severity
por: Hosch, René, et al.
Publicado: (2022)

Semileptonic KL Decays at NA48
por: Veltri, M.
Publicado: (2004)

Collaboration Agreement No. Kl148/AB
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2005)

Form factor for the Dalitz decay of KL
por: Terasaki, K
Publicado: (1996)

The $Kl _{3}$ puzzle and current algebra
por: Banerjee, H
Publicado: (1970)

KL-6 levels in COVID-19
por: Scarpati, G, et al.
Publicado: (2020)

Association between habitual physical activity (HPA) and sleep quality in patients with cystic fibrosis
por: Dietz-Terjung, Sarah, et al.
Publicado: (2020)

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
por: Ono, Takashi, et al.
Publicado: (2020)

An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa
por: Sutharsan, Sivagurunathan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i34po49kj10a8k7212om0uhtod